News

Yahoo Finance5mon
Beta Lactam and Beta Lactamase Inhibitors Market to grow by USD 8.4 Billion from 2025-2029, driven by novel drug development, with AI driving market transformation - Technavio
These advancements contribute to the discovery of improved beta lactam antibiotics and beta lactamase inhibitors, addressing antimicrobial resistance and infectious diseases.
Business Insider5y
The global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from ...
NEW YORK, Oct. 1, 2019 /PRNewswire/ -- Beta-lactam and Beta-lactamase Inhibitors Market by Drug Class (Penicillin, Cephalosporin, Carbapenem, Monobactam, and Combination), Disease (Urinary Tract ...
PharmiWeb1y
Beta-lactam and Beta-lactamase Inhibitors Market: Emerging Trends and Therapeutic Innovations for Antibiotic Resistance
The Beta-lactam and Beta-lactamase Inhibitors Market encompasses a wide range of antibiotics and enzyme inhibitors used in the treatment of various bacterial infections. Beta-lactams are a class of ...
Yahoo Finance4mon
Beta Lactam and Beta Lactamase Inhibitors Market to grow by USD 8.4 Billion (2025-2029), driven by novel drug development, AI-powered market evolution - Technavio
Amalgamation traits of Beta Lactam and Beta Lactamase Inhibitors offer effective solutions to combat antibiotic resistance. Creative Diagnostics is a leading supplier of Beta Lactamase Inhibitors ...